TATE

FASENRA approved for treatment of children aged 6 to 11 with severe asthma

Retrieved on: 
Thursday, April 11, 2024
Health, FDA, General Health, Research, Science, Pharmaceutical, Biotechnology, Efficacy, Safety, Gastroenterology, HES, Chronic obstructive pulmonary disease, Sinusitis, Social media, Polyp (medicine), Pharmacokinetics, Rheumatology, Conference call, Asthma, TATE, AstraZeneca, FY, Hypereosinophilic syndrome, Death, ClinicalTrials.gov, Dermatology, Conference, COPD, Webcast, Growth, Disease, Vasculitis, Respiratory Medicine, EGPA, Immunology, Metabolism, Diagnosis, Biomarker, PD, Biopharmaceutical, Ageing, Pharmaceutical industry

TATE was an open-label, Phase III trial evaluating the safety of FASENRA in children aged 6 to 11 years with severe eosinophilic asthma.

Key Points: 
  • TATE was an open-label, Phase III trial evaluating the safety of FASENRA in children aged 6 to 11 years with severe eosinophilic asthma.
  • The Company aims to transform the treatment of asthma and COPD by focusing on earlier biology-led treatment, eliminating preventable asthma attacks, and removing COPD as a top-three leading cause of death.
  • Benralizumab in children with severe eosinophilic asthma: pharmacokinetics and long-term safety (TATE study).
  • Severe uncontrolled asthma in children: practical approach on diagnosis and management.

Teclison Announces Publication of Phase 1 Data Demonstrating the Safety and Therapeutic Potential of Tirapazamine Chemoembolization for Patients with Unresectable Liver Cancer

Retrieved on: 
Tuesday, June 21, 2022
Doctor of Philosophy, TACE, Tirapazamine, Fever, FDA, Therapy, Journal, HCC, Safety, B cell, BCLC, Radiofrequency ablation, CEO, Liver, Survival, Tumor necrosis factor, Recurrence, Liver cancer, TATE, MD, GLOBE, Immunotherapy, Doxorubicin, Journal of Vascular and Interventional Radiology, Hepatocellular carcinoma, Patient, Abdominal pain, Neoplasm, Necrosis, ECG, Interventional radiology, TPZ, Medical imaging, Pharmaceutical industry

PRINCETON, N.J., and TAIPEI, Taiwan, June 21, 2022 (GLOBE NEWSWIRE) -- Teclison, a clinical-stage biotechnology company developing innovative cancer therapeutics to induce tumor necrosis and enhance anti-tumor immunity, today announced the peer-reviewed publication of a study demonstrating the safety, tolerability and preliminary efficacy of its trans-arterial tirapazamine chemoembolization (TATE) therapy in patients with unresectable early- and intermediate-stage hepatocellular carcinoma (HCC), also known as liver cancer. The clinical data, published in The Journal of Vascular and Interventional Radiology titled “Phase I Dose-Escalation Study of Tirapazamine Chemoembolization for Unresectable Early- and Intermediate-Stage Hepatocellular Carcinoma,” establishes tirapazamine, a hypoxia-activated anti-cancer drug, as safe when administered in conjunction with trans-arterial embolization with promising efficacy in patients with liver cancer, including those with progression or recurrence after treatment with conventional trans-arterial chemoembolization (TACE).

Key Points: 
  • The current standard of care for unresectable liver cancer is conventional trans-arterial chemoembolization with the chemotherapeutic agent doxorubicin.
  • The results of this study support tirapazamine as an alternative to doxorubicin in trans-arterial chemoembolization.
  • Seventeen patients with unresectable early-stage HCC or unresectable intermediate-stage HCC were enrolled in this non-randomized, open-label Phase 1 study.
  • A Phase 2 randomized study comparing efficacy of TATE vs TACE in patients with intermediate liver cancer is underway.

S.PELLEGRINO YOUNG CHEF ACADEMY PRESENTS THE GLOBAL JURY FOR THE GRAND FINALE OF S.PELLEGRINO YOUNG CHEF ACADEMY COMPETITION 2022-23

Retrieved on: 
Friday, June 17, 2022
Culture, Intuition, Creativity, MILAN, Grand Finale, Cooking, Health, Young Chef Olympiad, Academy, Mineral, Connacht, International school, Life, Sage, Time, Heart, Joxe Azurmendi, Le Manoir, Female, National Gallery Singapore, Mentorship, Foundation, Food, Restaurant, Capcom Pro Tour 2017 regional finals, Seven Sages, The World's 50 Best Restaurants, World, Dream, Instinct, Knowledge, Baker, Cheese, Pirandello, History, Ethics, Multimedia, Michelin, Advertising, James Beard Foundation Award, Silverton, Solidarity, ALMA, Central, Bread, Hand, Growth, TATE, Pleasure, Top Chef, Energy drink, Press release, Competition, Goal, Coffee, Odette

MILAN, June 17, 2022 /PRNewswire/ -- The S.Pellegrino Young Chef Academy is proud to announce the "Seven Sages", the jurors who will be judging the Grand Finale of the S.Pellegrino Young Chef Academy Competition 2022-23, taking place in Milan by September 2023.

Key Points: 
  • MILAN, June 17, 2022 /PRNewswire/ -- The S.Pellegrino Young Chef Academy is proud to announce the "Seven Sages", the jurors who will be judging the Grand Finale of the S.Pellegrino Young Chef Academy Competition 2022-23, taking place in Milan by September 2023.
  • Eneko Atxa, the Basque chef owns 5 Michelin stars thanks to his restaurants Azurmendi and ENEKO.
  • The S.Pellegrino Young Chef Academy Competition will offer a unique opportunity for young chefs to participate in the S.Pellegrino Young Chef Academy.
  • S.Pellegrino, Acqua Panna and Sanpellegrino Italian Sparkling Drinks are international trademarks of Sanpellegrino S.p.A., which is based in Milan, Italy.

S.PELLEGRINO YOUNG CHEF ACADEMY PRESENTS THE GLOBAL JURY FOR THE GRAND FINALE OF S.PELLEGRINO YOUNG CHEF ACADEMY COMPETITION 2022-23

Retrieved on: 
Friday, June 17, 2022
Culture, Intuition, Creativity, MILAN, Grand Finale, Cooking, Health, Young Chef Olympiad, Academy, Mineral, Connacht, International school, Life, Sage, Time, Heart, Joxe Azurmendi, Le Manoir, Female, National Gallery Singapore, Mentorship, Foundation, Food, Restaurant, Capcom Pro Tour 2017 regional finals, Seven Sages, The World's 50 Best Restaurants, World, Dream, Instinct, Knowledge, Baker, Cheese, Pirandello, History, Ethics, Michelin, Advertising, James Beard Foundation Award, Silverton, Solidarity, ALMA, Central, Bread, Hand, Growth, TATE, Pleasure, Top Chef, Energy drink, Press release, Competition, Goal, Coffee, Odette

MILAN, June 17, 2022 /PRNewswire/ -- The S.Pellegrino Young Chef Academy is proud to announce the "Seven Sages", the jurors who will be judging the Grand Finale of the S.Pellegrino Young Chef Academy Competition 2022-23, taking place in Milan by September 2023.

Key Points: 
  • MILAN, June 17, 2022 /PRNewswire/ -- The S.Pellegrino Young Chef Academy is proud to announce the "Seven Sages", the jurors who will be judging the Grand Finale of the S.Pellegrino Young Chef Academy Competition 2022-23, taking place in Milan by September 2023.
  • Eneko Atxa, the Basque chef owns 5 Michelin stars thanks to his restaurants Azurmendi and ENEKO.
  • The S.Pellegrino Young Chef Academy Competition will offer a unique opportunity for young chefs to participate in the S.Pellegrino Young Chef Academy.
  • S.Pellegrino, Acqua Panna and Sanpellegrino Italian Sparkling Drinks are international trademarks of Sanpellegrino S.p.A., which is based in Milan, Italy.

Wakatta partners up with .ART to bring NFT-powered solutions to 150,000 artists

Retrieved on: 
Wednesday, December 1, 2021
Non-fungible token, Sport, Technology, Industry, Hand, Partnership, TATE, Blockchain, Art, Louis Vuitton Foundation, Intellectual property, Creativity, Digital twin, Marina Abramović, Digital, Ownership, NFT, Internet, Business development, Cryptocurrency, Creative industries

Additional features powered by Wakatta will include on-chain auctions, NFT ownership certificates and incentives for artist collaborations.

Key Points: 
  • Additional features powered by Wakatta will include on-chain auctions, NFT ownership certificates and incentives for artist collaborations.
  • Ever since the launch of .ART we have been integrating various blockchain solutions and are thrilled to welcome Wakatta as one of our partners.
  • "Wakatta was designed with the primary goal of empowering artists and creators in the entertainment sphere.
  • Wakatta is an NFT-focused blockchain for the entertainment industry pioneering new types of non-fungible tokens: upgradable, time-limited, and non-hashed NFTs.